Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Cao, Xiao Lin ^a   Li, Hua ^a,b   Yu, Xiao Ling ^a   Liang, Ping ^a   Dong, Bao Wei ^a   Fan, Jin ^a   Li, Meng ^a   Liu, Fang Yi ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b General Hospital of Chinese People's Liberation Army   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DECISION TREE; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; RADIATION APPLICATOR; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

AGED; BLOOD PROTEINS; CARCINOMA, HEPATOCELLULAR; DECISION TREES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MICROWAVES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; PROGNOSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84892650500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082448     Document Type: Article

References (38)

1. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543.
2. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243: 229-235.
3. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, et al. (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103: 1856-1864.
4. Wang Y, Sun Y, Feng L, Gao Y, Ni X, et al. (2008) Internally cooled antenna for microwave ablation: results in ex vivo and in vivo porcine livers. Eur J Radiol 67: 357-361.
5. Wang ZL, Liang P, Dong BW, Yu XL, Yu de J (2008) Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J Gastrointest Surg 12: 327-337.
6. Liotta LA, Ferrari M, Petricoin E (2003) Clinical proteomics: written in blood. Nature 425: 905.
7. Gilbert K, Figueredo S, Meng XY, Yip C, Fung ET (2004) Serum protein-expression profiling using the ProteinChip biomarker system. Methods Mol Biol 264: 259-269.
8. Kuwata H, Yip TT, Yip CL, Tomita M, Hutchens TW (1998) Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. Biochem Biophys Res Commun 245: 764-773.
9. Wulfkuhle JD, Liotta LA, Petricoin EF (2003) Proteomic applications for the early detection of cancer. Nat Rev Cancer 3: 267-275.
10. Albitar M, Potts SJ, Giles FJ, O'Brien S, Keating M, et al. (2006) Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer 106: 1587-1594.
11. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, et al. (2007) Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 4: e18.
12. Purohit S, Podolsky R, Schatz D, Muir A, Hopkins D, et al. (2006) Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery. Proteomics 6: 6405-6415.
13. He QY, Zhu R, Lei T, Ng MY, Luk JM, et al. (2008) Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma. J Cell Biochem 103: 740-752.
14. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, et al. (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41: 40-47.
15. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577.
16. Langbein S, Lehmann J, Harder A, Steidler A, Michel MS, et al. (2006) Protein profiling of bladder cancer using the 2D-PAGE and SELDI-TOF-MS technique. Technol Cancer Res Treat 5: 67-72.
17. Xue A, Gandy RC, Chung L, Baxter RC, Smith RC (2012) Discovery of diagnostic biomarkers for pancreatic cancer in immunodepleted serum by SELDI-TOF MS. Pancreatology 12: 124-129.
18. Navaglia F, Fogar P, Basso D, Greco E, Padoan A, et al. (2009) Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry. Clin Chem Lab Med 47: 713-723.
19. Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faca VM, et al. (2011) Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 20: 289-299.
20. Semmes OJ, Malik G, Ward M (2006) Application of mass spectrometry to the discovery of biomarkers for detection of prostate cancer. J Cell Biochem 98: 496-503.
21. Liang P, Yu J, Yu XL, Wang XH, Wei Q, et al. (2012) Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut 61: 1100-1101.
22. Liang P, Wang Y (2007) Microwave ablation of hepatocellular carcinoma. Oncology 72 Suppl 1: 124-131.
23. Solbiati L, Tonolini M, Cova L (2004) Monitoring RF ablation. Eur Radiol 14 Suppl 8: P34-42.
24. Liu F, Yu X, Liang P, Cheng Z, Han Z, et al. (2011) Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound. Int J Hyperthermia 27: 555-562.
25. Nicolau C, Vilana R, Bianchi L, Bru C (2007) Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol 17 Suppl 6: F80-88.
26. Imura S, Shimada M, Utsunomiya T, Morine Y, Ikemoto T, et al. (2012) Ultrasound-guided microwave coagulation assists anatomical hepatic resection. Surg Today 42: 35-40.
27. Aramaki M, Kawano K, Ohno T, Sasaki A, Tahara K, et al. (2004) Microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology 51: 1784-1787.
28. Veltri A, Gazzera C, Rotondella C, Camerano F, Busso M, et al. (2012) Image-guided microwave ablation of hepatic tumours: preliminary experience. Radiol Med 117: 378-392.
29. Okuda K (2000) Hepatocellular carcinoma. J Hepatol 32: 225-237.
30. Tsunedomi R, Iizuka N, Tamesa T, Sakamoto K, Hamaguchi T, et al. (2008) Decreased ID2 promotes metastatic potentials of hepatocellular carcinoma by altering secretion of vascular endothelial growth factor. Clin Cancer Res 14: 1025-1031.
31. Yamashiki N, Yoshida H, Tateishi R, Shiina S, Teratani T, et al. (2007) Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment. J Gastroenterol Hepatol 22: 2155-2160.
32. Vascotto C, Cesaratto L, D'Ambrosio C, Scaloni A, Avellini C, et al. (2006) Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics 6: 3455-3465.
33. Ostroff RM, Mehan MR, Stewart A, Ayers D, Brody EN, et al. (2012) Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One 7: e46091.
34. Zeindl-Eberhart E, Haraida S, Liebmann S, Jungblut PR, Lamer S, et al. (2004) Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 39: 540-549.
35. Chignard N, Beretta L (2004) Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology 127: S120-125.
36. Steel LF, Mattu TS, Mehta A, Hebestreit H, Dwek R, et al. (2001) A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. Dis Markers 17: 179-189.
37. Schwegler EE, Cazares L, Steel LF, Adam BL, Johnson DA, et al. (2005) SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. Hepatology 41: 634-642.
38. Ward DG, Cheng Y, N'Kontchou G, Thar TT, Barget N, et al. (2006) Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis. Br J Cancer 94: 287-292.